This article below claims Pfizers interest and involvement in the industry has been growing since at least 2001. Direct from Monsantos own website link Monsanto Prior to Sept. 1, 1997, a corporation that was then known as Monsanto Company (Former Monsanto) operated an agricultural products business (the Ag Business), a pharmaceuticals and nutrition business (the Pharmaceuticals Business) and a chemical products business (the Chemicals Business). Former Monsanto is today known as Pharmacia. Pharmacia is now a wholly owned subsidiary of Pfizer Inc., which together with its subsidiaries operates the Pharmaceuticals Business. Today’s Monsanto includes the operations, assets and liabilities that were previously the Ag Business. Today’s Solutia comprises the operations, assets and liabilities that were previously the Chemicals Business. The following table sets forth a chronology of events that resulted in the formation of Monsanto, Pharmacia and Solutia as three separate and distinct corporations, and it provides a brief background on the relationships among these corporations. This shows that Pfizer is now the Parent company of Monsantos former pharmaceutical division. Link Large pharmaceutical companies such as Pfizer, GlaxoSmithKline and Novartis are demonstrating increasing interest in the therapeutic use of cannabinoids and their derivatives, according to a report of the Wall Street Journal on 28 February 2001. Other firms are already conducting research, such as the researchers at the Bayer AG who found that cannabinoid CB(1) receptors were upregulated in a rat model of chronic neuropathic pain (Siegling et al. 2001). Today, the only available cannabinoids are THC (dronabinol, Marinol) and the dronabinol derivative nabilone. Individual scientists, academic labs and small drug firms are currently the main promoters of pharmaceutical research, because large drug companies have traditionally been reserved with regard to the cost and the political problems associated with marketing marijuana as medicine. This situation appears to be changing. “We see them -- Pfizer, GlaxoSmithKline, Novartis -- all the time at the meetings of the society now, says Roger Pertwee, professor at the University of Aberdeen in the U.K. and secretary of the International Cannabinoid Research Society (ICRS). They never came in the past. Dow chemical, Bayer crop Science, Novartis, Syngenta and Monsato (now a subsidiary of Pfizer) are 5 of the biggest companies in the GMO business today.
Posted on: Thu, 10 Jul 2014 01:46:34 +0000
Trending Topics
Recently Viewed Topics
© 2015